P203 Effectiveness of anti-IL4R therapy following Suboptimal Response to anti-IL5/5R therapy in severe eosinophilic asthma

Asthma: phenotyping and the response to biologics Pub Date : 2021-11-01 DOI:10.1136/thorax-2021-btsabstracts.312

Twila A. Mason, A. Hearn, G. d'Ancona, M. Fernandes, C. Roxas, L. Green, L. Thomson, J. Dhariwal, A. Nanzer, D. Jackson

引用次数: 0

Abstract

P205 Figure 1 Poster sessions A178 Thorax 2021;76(Suppl 2):A1–A205 on N ovem er 0, 2021 by gest. P rocted by coright. httphorax.bm jcom / T hrax: frst pulished as 10.113orax-2021-B T S abscts.312 on 8 N ovem er 221. D ow nladed fom

查看原文本刊更多论文

P203严重嗜酸性粒细胞哮喘患者抗il5 / 5r治疗次优反应后抗il4r治疗的有效性

P205图1海报由科里特载。httphorax。bm jcom / T hrax:首先从10113orax -2021- b b abc撤退。312年8月221年。他被烧伤了

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asthma: phenotyping and the response to biologics

自引率

0.00%

发文量